In a win for industry, Trump administration issues scathing review of Pelosi drug pricing bill

President Donald Trump wants it both ways — cheaper drugs and vigorous innovation. Earlier this year, the Democrats’ revealed their drug pricing bill, which is engineered to empower the HHS to negotiate prices for select drugs. The White House has now emerged as one of its harshest critics.